Company: AZN
Filing Date: 2025-03-07
Form Type: 6-K
Source: 0001654954-25-002413
Chunk: 1

Company: ASTRAZENECA PLC
Filing Date: 2025-03-07
Form: 6-K
Chunk 1
---
 today.

The business to be conducted at the AGM is summarised below:

1. To receive the Company's Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2024

2. To confirm the 2024 interim dividends

3. To re-appoint PricewaterhouseCoopers LLP as Auditor

4. To authorise the Directors to agree the remuneration of the Auditor

5. To elect or re-elect Directors

6. To approve the annual statement of the Chair of the Remuneration Committee and the Annual Report on Remuneration for the year ended 31 December 2024

7. To authorise limited political donations

8. To authorise the Directors to allot shares

9. To authorise the Directors to disapply pre-emption rights

10. To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments

11. To authorise the Company to purchase its own shares

12. To reduce the notice period for general meetings

Pursuant to Regulation 41 of the Uncertificated Securities Regulations 2001, only holders of ordinary shares entered in the register of members of the Company by 18:30 (BST) on 9 April 2025 (or their duly appointed proxies), or if this meeting is adjourned, in the register of members by 18:30 (BST) two days prior to any adjourned meeting, are entitled to attend or vote at the AGM in respect of the number of ordinary shares registered in their name at that time. Changes to the entries in the register of members after 18:30 (BST) on 9 April 2025, or if this meeting is adjourned, in the register of members after 18:30 (BST) two days prior to any adjourned meeting, shall be disregarded in determining the rights of any person to attend or vote at the AGM. The Record Date applied to the Euroclear Sweden system to determine entitlement to participate and vote at the AGM is close of business on 2 April 2025. The Record Date to determine entitlement to participate and vote at the AGM for registered holders of the Company's American Depositary Receipts is close of business on 25 February 2025.

#### AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that